Treatment with PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia Lowers Plasma Levels of Platelet-Activating Factor and Its Precursors: A Combined Metabolomic and Lipidomic Approach

Introduction: Familial hypercholesterolemia (FH) is characterized by extremely high levels of circulating low-density lipoprotein cholesterol (LDL-C) and is caused by mutations of genes involved in LDL-C metabolism, including LDL receptor (LDLR), apolipoprotein B (APOB), or proprotein convertase sub...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Alessandro Di Minno, Roberta Clara Orsini, Mattia Chiesa, Viviana Cavalca, Ilenia Calcaterra, Maria Tripaldella, Andrea Anesi, Susanna Fiorelli, Sonia Eligini, Gualtiero I. Colombo, Elena Tremoli, Benedetta Porro, Matteo Nicola Dario Di Minno
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	MDPI AG 2021-08-01
Reeks:	Biomedicines
Onderwerpen:	PCSK9 untargeted metabolomics familial hypercholesterolemia
Online toegang:	https://www.mdpi.com/2227-9059/9/8/1073
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!